BCIQ Profiles

Company Profile ReportTarget Profile Report

Cancer; infectious disease

INDICATION: Acute myelogenous leukemia (AML); Candida

In vitro, cell culture and mouse studies identified an aminopyrimidine-based dual JAK-2/HDAC6 inhibitor

Read the full 187 word article

How to gain access

Continue reading with a
two-week free trial.